Larimar Therapeutics Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: LRMR
Share price (8/6/26): $4.20
Market cap (8/6/26): $436 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from DEFA14A 5 pages Amendment No. 1 Agreement and Plan of Merger Among: Zafgen, Inc.; Zordich Merger Sub, Inc.; Chondrial Therapeutics, Inc.; and Chondrial Therapeutics Holdings, LLC Dated as of March 6, 2020

from 8-K 5 pages Amendment No. 1 Agreement and Plan of Merger Among: Zafgen, Inc.; Zordich Merger Sub, Inc.; Chondrial Therapeutics, Inc.; and Chondrial Therapeutics Holdings, LLC Dated as of March 6, 2020

from DEFA14A 104 pages Agreement and Plan of Merger Among: Zafgen, Inc.; Zordich Merger Sub, Inc.; Chondrial Therapeutics, Inc.; and Chondrial Therapeutics Holdings, LLC Dated as of December 17, 2019

from 8-K 104 pages Agreement and Plan of Merger Among: Zafgen, Inc.; Zordich Merger Sub, Inc.; Chondrial Therapeutics, Inc.; and Chondrial Therapeutics Holdings, LLC Dated as of December 17, 2019